Coombes RC, Tovey H, Kilburn L, et al. A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT – Randomised EuropeAn celecoxib trial). SABCS 2017, GS3-03.
Atezolizumab verbetert PFS 'triple-negatieve' borstkanker
jul 2018 | Borstkanker, Immuuntherapie